Enantioselective drug monitoring of (R)- and (S)- propranolol in human plasma via derivatization with optically active (R,R)-O,O-diacetyl tartaric acid anhydride.
W Lindner, M Rath, K Stoschitzky, G Uray
Index: J. Chromatogr. A. 487 , 375, (1989)
Full Text: HTML
Abstract
A sensitive high-performance liquid chromatographic method was developed for the stereoselective assay of (R)- and (S)-propranolol in human plasma. The method involves diethyl ether extraction of the drugs and a racemic internal standard, N-tert.-butylpropranolol, followed by derivatization of the compounds with the chiral reagent (R,R)-O,O-diacetyl tartaric acid anhydride. The resulting diastereomeric derivatives were separated isocratically on a reversed-phase column. Quantitation was achieved by the peak-height ratio method with reference to the internal standard. The assay was accurate and reproducible in the concentration range 1-100 ng of (R)- and (S)-propranolol per ml plasma, using fluorescence detection at lambda ex 290 nm and lambda em 335 nm. The applicability of this method was demonstrated for the determination of concentration-time profiles of propranolol enantiomers in the course of comparative pharmacokinetic studies.
Related Compounds
Related Articles:
[J. Chromatogr. A. 581(1) , 83-92, (1992)]
2004-08-01
[Clin. Chem. 50(8) , 1391-5, (2004)]
1994-06-01
[Electrophoresis 15(6) , 769-73, (1994)]
2011-01-01
[PLoS ONE 6 , e16812, (2011)]
1995-06-01
[J. Pharm. Biomed. Anal. 13(7) , 911-8, (1995)]